The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance

Article ID	Journal	Published Year	Pages	File Type
4277158	Urology Practice	2015	9 Pages	PDF

Abstract

This study demonstrates that the 17-gene GPS influenced treatment recommendations among urologists and provided increased confidence in these recommendations in patients at NCCN very low to low-intermediate risk.

Keywords

ADT PSA Gleason pattern EBRT PCA Prostate specific antigen Risk assessment Molecular diagnostic techniques ADT, Androgen deprivation therapy Radical prostatectomy GPS Prostate cancer Prostatic neoplasms biological markers Active surveillance Genomic Prostate Score Gleason score external beam radiation therapy Columbia Lymph node

Related Topics

Health Sciences Medicine and Dentistry Urology

Preview

The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance

Authors

Ketan K. Badani, Michael J. Kemeter, Phillip G. Febbo, H. Jeffrey Lawrence, Béla S. Denes, Megan P. Rothney, Michael B. Rothberg, Gordon A. Brown,